Keywords: USA, GPhA, Generic competition, Patent settlements, Lipitor, Pfizer, Watson, Ranbaxy

US launch of generic Lipitor confirms value of competition, says GPhA

Article | 01 December 2011

Print This

Commenting on this week’s US roll out for generic copies of Pfizer blockbuster cholesterol lowerer Lipitor (atorvastatin) by ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in